Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Impact of Peripheral Neuropathy in Type-II Diabetes Mellitus on Outcome Measures of Weight-Bearing Aerobic Training in Post-Myocardial Infarction Patients.
Verified date | April 2019 |
Source | University of Alexandria |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cardiac rehabilitation (CR) is categorized by the American College of Cardiology "class IA
recommendation" in the management of patients with cardiovascular disease (CVD) including
post-myocardial infarction (MI) patients, who have reduced functional capacity and impaired
quality of life. Studies have reported that post-MI patients enrolled in exercise-based CR
(EB-CR) show improved functional capacity, significant decrease risk of re-infarction, and
25% reduction in mortality. Aim: To define the effect of diabetic peripheral neuropathy (DPN)
on the outcome measures of exercise based-cardiac rehabilitation (EB-CR) program in
post-myocardial infarction (MI) patients with type-II diabetes mellitus (DM).
Methods: Thirty-seven post-MI patients with type-II DM were enrolled in the study within 1-6
months of MI from those referred for cardiac rehabilitation in the cardiac rehabilitation
unit, Alexandria Teaching Hospital. Seven patients were lost. Fifteen patients attended 8
weeks of aerobic training program (exercise group; 12 men and 3 women) while 15 patients did
not (control group; 11 men and 4 women). The exercise group was assessed for the presence of
peripheral neuropathy and patients were accordingly subdivided into those with DPN "group A"
and those without "group B". All groups were evaluated at baseline and at the end of the
study. Evaluation included Duke Activity Status Index (DASI) questionnaire, 6-minute walk
test, and symptom-limited treadmill exercise stress test (EST).
Outcome measures included: DASI score; 6-minute walk test distance (6MWD); and heart rate
(HR), blood pressure (BP), rate pressure product (RPP), and functional capacity in metabolic
equivalents (METs) measured during EST.
Status | Completed |
Enrollment | 37 |
Est. completion date | September 30, 2018 |
Est. primary completion date | May 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - diagnosed as having MI according to the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of MI - DM according to the 2016 American Diabetes Association guidelines Exclusion Criteria: - contraindication to exercise stress test (EST) - contraindication to cardiac rehabilitation, - systemic illness other than DM or hypertension, - neurological disorders other than DPN, - had loss of protective sensation (anesthesia) - had ulcerations in the lower limbs. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Yousra Hisham Abdel Fattah | Aya Hanafy Ibrahiem, Diaa Mohamed Mohasseb, Gihan Younis El-tantawi, Mahmoud Mohamed Hassanein |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duke Activity Status Index (DASI) questionnaire | 12 questions of self-administered questionnaire that measures a patient's functional capacity, The index included questions about activities of daily living as personal care, house hold activities and recreational activities. It also correlated activities with peak oxygen uptake. Maximum value 58.2 and Minimum value 0, higher values indicate better functional capacity. Estimated peak oxygen uptake in mL/min = (0.43 * (duke activity status index) + 9.6 |
8 weeks | |
Primary | heart rate (HR) | number of heart beats per minute, | 8 weeks | |
Primary | blood pressure (BP), | systolic and diastolic blood pressure in mmHg | 8 weeks | |
Primary | rate pressure product (RPP), | is a measure of the stress put on the cardiac muscle based on the number of times it needs to beat per minute (HR) and the arterial blood pressure that it is pumping against | 8 weeks | |
Primary | Six minute walk test distance | It is used to estimate the functional capacity of the study group. It was done according to the American Thoracic Society (ATS) guidelines for the 6MWT. The 6MWT was performed in an indoors flat straight corridor of 30 meters in length. A stopwatch was used to measure the 6 minutes. Patients were instructed that the target of the test was to: WALK AS FAR AS POSSIBLE for 6 minutes, WITHOUT RUNNING OR JOGGING |
8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |